Adenosine uptake and deamination regulate tonic A(2a) receptor facilitation of evoked [H-3]acetylcholine release from the rat motor nerve terminals

• Type: Article in International Scientific Journal
• Date: 1996

Authors

Paulo Correia de Sá (Author) Other; Ribeiro, JA (Author) Other

Journal

Title: Neuroscience

Vol. 73

Pages: 85-92

ISSN: 0306-4522

Publisher: Elsevier

Indexing

ISI Web of Knowledge - 36 Citations

Scopus - 38 Citations

Other information

Authenticus ID: P-001-E3A

DOI: 10.1016/0306-4522(96)00028-0

Abstract (EN): The actions of adenosine, adenosine deaminase, the adenosine uptake blocker, S-(p-nitrobenzyl)-6-thioinosine, and of the adenosine deaminase inhibitor, erythro-9(2-hydroxy-3-nonyl)adenine, on electrically evoked [H-3]acetylcholine release were investigated in rat phrenic nerve-hemidiaphragm preparations. Adenosine deaminase (0.25-2.5 U/ml) increased [H-3]acetylcholine release. S-(p-Nitrobenzyl)-6-thioinosine (3-30 mu M) and erythro-9(2-hydroxy-3-nonyl)adenine (25 nM-50 mu M) caused biphasic effects on [H-3]acetylcholine release: at low concentrations S-(p-nitrobenzyl)-6-thioinosine (5 mu M) and erythro-9(2-hydroxy-3-nonyl)adenine (50 nM) decreased [SH]acetylcholine release, and at concentrations higher than 10 mu M S-(p-nitrobenzyl)-6-thioinosine and 0.5 mu M for erythro-9(2-hydroxy-3-nonyl)adenine facilitated [H-3]acetylcholine release. Both S-(p-nitrobenzyl)-6-thioinosine-induced inhibition and facilitation of [H-3]acetylcholine release resulted from extracellular endogenous adenosine accumulation, because they were blocked after inactivation of endogenous adenosine with adenosine deaminase (0.5 U/ml). The inhibitory actions of both S-(p-nitrobenzyl)-6-thioinosine (5 mu M) and erythro-9(2- hydroxy-3-nonyl)adenine (50 nM) were antagonized by the A(1) adenosine receptor antagonist, 1,3-dipropyl-8-cyclopentylxanthine (2.5 nM), whereas the blockade of A(2a) adenosine receptors with PD 115,199 (25 nM) prevented the facilitatory effects of S-(p-nitrobenzyl)-6-thioinosine (30 mu M) and erythro-9(2-hydroxy-3-nonyl)adenine (50 mu M). The adenosine deaminase inhibitor, erythro-9(2-hydroxy-3-nonyl)adenine (25 nM), potentiated the effect of S-(p-nitrobenzyl)-6-thioinosine (3-30 mu M), and this adenosine uptake blocker, when applied at a concentration (3 mu M) that by itself was devoid of effect, potentiated both the inhibitory (25 nM) and excitatory (0.5 mu M) effects of erythro-9(2-hydroxy-3-nonyl)adenine, on evoked [H-3]acetylcholine release. Exogenously applied adenosine (10-500 mu M) had biphasic effects similar to those of S-(p-nitrobenzyl)-6-thioinosine and erythro-9(2-hydroxy-3-nonyl)adenine. Adenosine (30 mu M) reduction of evoked [H-3]acetylcholine release was prevented after pretreatment with 1,3-dipropyl-b-cyclopentylxanthine (2.5 nM); when applied at high concentrations (100-500 mu M), adenosine consistently increased evoked [H-3]acetylcholine release in a PD 115,199 (25 nM)-sensitive manner. It is concluded that both uptake and deamination are effective in removing extracellular endogenous adenosine that tonically activates both inhibitory (A(1)) and excitatory (A(2a)) adenosine receptors, regulating the A(1)/A(2a) adenosine receptors' activation balance. (C) 1996 IBRO. Published by Elsevier Science Ltd.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 8